Order Entry
Canada
ContactUsLinkComponent
GLP-1 (9-36/37) (Human, Mouse, Rat), IBL-America
GLP-1 (9-36/37) (Human, Mouse, Rat), IBL-America
  102465-536
 :  
undefined
GLP-1 (9-36/37) (Human, Mouse, Rat), IBL-America
  102465-536
 :  27788
 :  

Some Products May Appear Restricted

To ensure a smooth and speedy checkout, please log in to your account. Some items may show as restricted simply because you're not logged in.

If you do not have an account, you can register using our registration webform (https://www.avantorsciences.com/ca/en/login/register)

 

If you're still seeing restrictions after logging in, certain products—like chemicals or medical devices—require additional account verification steps to be able to place an order. Some items may additionally require a specific license or customer documentation;  additional documentation will be requested for these items prior to shipment. 

 

  • Primary antibody reactivity:
    Human
  • Description:
    GLP-1 (9-36/37) (Human, Mouse, Rat) ELISA
  • Cat. no.:
    102465-536
  • Supplier No.:
    27788

 

 

Solid phase, sandwich ELISA for the determination of Inactive form of GLP-1 (9-36/37) in human, mouse and rat EDTA plasma, and in cell culture supernatant.

  • For research use only, not for use in diagnostic procedures
  • Quantitatively measure inactive forms of GLP-1
  • Determine GLP-1 in cell culture supernatant

GLP-1 (Glucagon Like Peptide-1) is a transcriptional product of proglucagon gene. This is the same as glucagon and one of the gastrointestinal hormones which is secreted from L cells of the lower section of the small intestine. GLP-1 (7-36) amide and GLP-1 (7-37) are active forms and these peptides are dissolved in blood by DDP4 (dipeptidyl peptidase-4) into GLP-1 (9-36) amide and GLP-1 (9-37) and these peptides lose their activities in a short period. GLP-1 is known as incretin, the same as GIP (Glucose-dependent Insulinotropic Polypeptide). It promotes secretion of insulin from β cells of the isles of Langerhans in the pancreas as glucose dependently. GLP-1 also suppresses secretion of glucagon from α cell of pancreas and concentration of glucose in blood after meals. Drugs of type 2 diabetes have been developed by utilizing the functional mechanism of GLP-1 such as blood sugar control through the pancreas, delayed gastric emptying and appetite suppression which contributes weight loss as extra-pancreatic effects. This ELISA kit can quantitatively measure inactive forms of GLP-1 such as GLP-1 (9-36) amide and GLP-1 (9-37) specifically. It can also quantitatively measure total GLP-1 in EDTA-plasma which does not contain DPP4 inhibitor since active forms GLP-1 in blood are rapidly transformed to inactive forms in two to five minutes in a half-period.